PacBio has delivered its first Vega systems to Berry Genomics as part of an early access agreement aimed at developing and optimizing targeted assays for carrier, prenatal, and newborn screening in ...

HiFi Long-Read Sequencing Panel Supports Comprehensive Analysis of 20 Genes Associated With Neurological Disease MENLO PARK, Calif., March 12, 2024 /PRNewswire/ -- PacBio (PACB) (NASDAQ: PACB), a ...

MENLO PARK, Calif., Oct. 31, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has begun taking orders for its ...

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced plans to pursue a strategic collaboration ...

MENLO PARK, Calif., Feb. 5, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced two new high throughput library ...

PacBio received $48.1 million in net cash proceeds from the transaction. Under the terms of the agreement, Illumina assumed certain liabilities and granted a non-exclusive license certain intellectual ...

Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other ...

Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.